Type 2 Diabetes Treated With Insulin Clinical Trial
Official title:
Is it Time to Revise Type 2 Diabetes Treatment: C-peptide Concentrations in Type 2 Diabetes Treated With Insulin
C-peptide is used to evaluate beta cell reserves. Patients with type 2 diabetes are treated with insulin for different indications. Other than beta-cell insufficiency and organ failures, insulin treatment is needed for a specified period. The investigators want to evaluate beta cell reserves in patients with type 2 diabetes treated with insulin for at least six months to see if that is the case. The investigators also want to compare the characteristics of these patients according to their beta cell reserves.
In patients with type 2 diabetes, initiation of insulin therapy is indicated in several conditions such as severe insulin resistance, acute metabolic decompensations, surgery, pregnancy, and progression of diabetic complications, and also when glycemic control cannot be achieved with effective lifestyle regulation and non-insulin antidiabetic medications. Some of these indications are transient, and patients should be reassessed to choose the appropriate treatment options. Clinical inertia is one of the new topics expressed in the recent diabetes guidelines. The investigators aimed to investigate the beta cell reserves of the patients with type 2 diabetes who are treated with insulin, to see if they have insufficient insulin secretion and if not, to compare their characteristics. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04522882 -
Clinical Data Collection for the Closed Loop Development for the Type 2 Diabetes Treatment - DT2_1
|
N/A | |
| Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
| Not yet recruiting |
NCT05185518 -
Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT05893797 -
A Study of LY8888AX in Participants Using a Connected Insulin Management Platform
|
N/A | |
| Completed |
NCT02791295 -
Lifestyle Intervention in Type 2 Diabetes
|
N/A | |
| Withdrawn |
NCT04957173 -
Intensive Lifestyle Intervention in Patients With Insulin-treated Type 2 Diabetes: a Pilot Project
|
N/A | |
| Not yet recruiting |
NCT05317585 -
Continuous Glucose Monitor Use in Pregnancy
|
N/A | |
| Completed |
NCT05372471 -
Efficacy of the Digital Platform for Diabetes Care Compared to Usual Care in Patients Diagnosed With Type 2 Diabetes.
|
N/A | |
| Completed |
NCT05111301 -
Control-IQ Technology in Individuals With Type 2 Diabetes
|
N/A | |
| Active, not recruiting |
NCT04585191 -
Reducing Treatment Risk in Older Adults With Diabetes
|
N/A | |
| Recruiting |
NCT04871438 -
Flash CONtinous Glucose Monitoring in TRansition to Outpatient: Libre for Type 2 Diabetes Mellitus (CONTROL-DM)
|
N/A | |
| Completed |
NCT06060743 -
Examining the Effect of Mobile Application on Insulin Use Perception and Self-Management
|
N/A | |
| Terminated |
NCT03980236 -
Feasibility of Using the Livongo-Insulia Study App for Patients With Type 2 Diabetes [Pilot Study]
|
N/A | |
| Not yet recruiting |
NCT06185296 -
The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy
|
N/A | |
| Completed |
NCT03437525 -
Peer Support in Diabetes Management - Insulin Peer Support
|
N/A | |
| Active, not recruiting |
NCT03070106 -
Diabetes: Functional Medicine Approach vs. Usual Care
|
N/A | |
| Completed |
NCT02060916 -
Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 Diabetes
|
Phase 2 | |
| Active, not recruiting |
NCT05785832 -
A Randomized Trial Evaluating Control-IQ Technology in Adults With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT04945070 -
INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi
|
Phase 4 | |
| Recruiting |
NCT05795439 -
The CARING Study: Creating and Restoring Health Through Nutrition Guidance
|
N/A |